Kymera Therapeutics Stock News & Updates
[WKN: A2QBSH | Symbol: KYMR]
Kymera Therapeutics: Specialist in Protein Degradation Addresses a $27 Billion Market with KT-621
Kymera Therapeutics focuses on targeted protein degradation with an emphasis on developing oral therapies...
Kymera Therapeutics - Clinical Study Data for KT-621 Creates Excitement!
Business Drivers: At Kymera Therapeutics (KYM ) is a biopharmaceutical company focused on developing...
US Markets Cautious Ahead of Fed Meeting - DAX Slightly Up - Paramount Outbids Netflix in Bidding War for Warner - Kymera Explodes After Positive Study on Inflammatory Drug - Carvana and CRH Added to S&P 500 - IBM Near Possible Acquisition of Confluent
Tech Stocks Lead the Market at the Start of the Week The US markets start cautiously into the week...
Stocks in Action USA: Warner Bros. Discovery, Kymera Therapeutics, Confluent
Paramount (PSKY) – Acquisition Offensive Against Warner Bros. Discovery (WBD Triggering Market Movement!...
Stocks in Action USA: Cleveland-Cliffs, Kymera Therapeutics, Blueprint Medicines
Trump's new tariffs send US steel stocks like Steel Dynamics (STLD) soaring! The stocks of American...
Weak US Industry and Trade Risks Weigh on Wall Street – Markets are Starting the Week With Losses - Trump's new Tariffs Make US Steel Stocks Explode – Numerous Biotech Stocks Benefit From Positive News - DAX Starts June With Losses – US Tariffs and Ukraine Conflict Weigh on Markets!
After a historic May rally, the start of June for the US stock markets is noticeably more restrained:...
- ‹
- 1
- ›